Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 17,408.0 | $1.3M | 0.30% | +6K | +55.0% | $74.48 | +7.3% |
| 62 | ZLAB | ZAI LAB LTD | Healthcare | 68,124.0 | $1.3M | 0.30% | +21K | +43.4% | $19.00 | +34.9% |
| 63 | GERN | GERON CORP | Healthcare | 1,011,201.0 | $1.3M | 0.30% | +390K | +62.9% | $1.28 | +19.5% |
| 64 | — | LEIDOS HOLDINGS INC | — | 12,495.0 | $1.3M | 0.30% | +2K | +23.2% | $102.97 | — |
| 65 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 40,155.0 | $1.3M | 0.30% | +17K | +75.0% | $31.75 | +10.4% |
| 66 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 23,351.0 | $1.3M | 0.30% | +8K | +56.8% | $54.54 | -0.5% |
| 67 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 15,605.0 | $1.3M | 0.30% | +4K | +29.6% | $81.51 | +8.8% |
| 68 | INSM | INSMED INC | Healthcare | 11,884.0 | $1.3M | 0.29% | +8K | +177.5% | $106.62 | +20.4% |
| 69 | OMER | OMEROS CORP | Healthcare | 133,129.0 | $1.3M | 0.29% | +106K | +395.6% | $9.51 | +82.5% |
| 70 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 33,736.0 | $1.3M | 0.29% | +17K | +101.8% | $37.42 | +126.5% |
| 71 | PTCT | PTC THERAPEUTICS INC | Healthcare | 15,476.0 | $1.3M | 0.29% | +4K | +38.7% | $81.57 | -10.7% |
| 72 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 15,870.0 | $1.3M | 0.29% | +5K | +51.9% | $79.29 | -26.1% |
| 73 | BIIB | BIOGEN INC | Healthcare | 5,813.0 | $1.3M | 0.29% | +965.0 | +19.9% | $216.06 | -3.2% |
| 74 | — | BEONE MEDICINES LTD | — | 4,397.0 | $1.3M | 0.29% | +2K | +66.2% | $284.97 | — |
| 75 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 47,698.0 | $1.3M | 0.29% | +19K | +64.0% | $26.22 | -2.3% |
| 76 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 73,507.0 | $1.2M | 0.29% | +20K | +38.0% | $16.97 | -9.9% |
| 77 | NVAX | NOVAVAX INC | Healthcare | 130,955.0 | $1.2M | 0.29% | +2K | +1.9% | $9.42 | -14.3% |
| 78 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 33,746.0 | $1.2M | 0.29% | +13K | +61.9% | $36.41 | +4.8% |
| 79 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 7,279.0 | $1.2M | 0.29% | +2K | +31.8% | $168.53 | -8.3% |
| 80 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 112,139.0 | $1.2M | 0.28% | +54K | +93.4% | $10.85 | -14.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%